Associated factors for recommending HBV vaccination to children among Georgian health care workers

BMC Infectious Diseases

Louise-Anne McNutt¹  Kenrad Nelson⁵  Jack DeHovitz⁷  Wayne Triner⁶  Dale Morse³  Marina Topuridze⁴  George Kamkamidze²  Maia Butsashvili⁴ 

[1] University at Albany, School of Public Health, Rensselaer, NY, USA;Maternal and Child Care Union, Tbilisi, Georgia;Division of Foodborne, Waterborne and Environmental Diseases at CDC, Atlanta, GA, USA;National Center for Disease Control and Public Health (NCDC), 9 Asatiani st., Tbilisi, 0177, Georgia;Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;Department of Emergency Medicine, at Albany Medical College, Albany, NY, USA;Department of Medicine, AT SUNY-Downstate Medical Center, Brooklyn, NY, USA

关键词: Newborns;    Health Care Worker;    Safety;    Vaccine;    Hepatitis B;   

Others  :  1158678
DOI  :  10.1186/1471-2334-12-362

 received in 2012-01-20, accepted in 2012-12-14,  发布年份 2012

【 摘 要 】

Background

Most cases of hepatitis B virus (HBV) infection and subsequent liver diseases can be prevented with universal newborn HBV vaccination. The attitudes of health care workers about HBV vaccination and their willingness to recommend vaccine have been shown to impact HBV vaccination coverage and the prevention of vertical transmission of HBV. The purpose of this study was to ascertain the factors associated with health care worker recommendations regarding newborn HBV vaccination.

Methods

A cross-sectional study of prevalence and awareness of hepatitis B and hepatitis B vaccine was conducted among randomly selected physicians and nurses employed in seven hospitals in Georgia in 2006 and 2007. Self-administered questionnaires included a module on recommendations for HBV, HCV and HIV.

Results

Of the 1328 participants included in this analysis, 36% reported recommending against hepatitis B vaccination for children, including 33% of paediatricians. Among the 70.6% who provided a reason for not recommending HBV vaccine, the most common concern was an adverse vaccine event. Unvaccinated physicians and nurses were more likely to recommend against HBV vaccine (40.4% vs 11.4%, PR 3.54; 95% CI: 2.38, 5.29). Additionally, health care worker age was inversely correlated with recommendations for HBV vaccine with older workers less likely to recommend it.

Conclusion

Vaccinating health care workers against HBV may provide a dual benefit by boosting occupational safety as well as strengthening universal coverage programs for newborns.

【 授权许可】

   
2012 Butsashvili et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Butsashvili M, Tsertsvadze T, McNutt LA, et al.: Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. Eur J Epidemiol 2001, 17(7):693-695.
• [2]Iashina TL, Favorov MO, Shakhgil'dian IV, Firsova SN, Eraliev AE, Zhukova LD, Reznichenko RG: The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity. Vopr Virusol 1992, 37(4):194-196.
• [3]Nurgalieva ZZ, Hollinger FB, Graham DY, Zhangabylova S, Zhangabylov A: Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan. World J Gastroenterol 2007, 13(8):1204-1207.
• [4]Zacharakis G, Koskinas J, Kotsiou S, Pouliou E, Papoutselis M, Tzara F, Vafeiadis N, Maltezos E, Archimandritis A, Papoutselis K: Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece. J Pediatr Gastroenterol Nutr 2007, 44(1):84-91.
• [5]Slowik MK, Jhaveri R: Hepatitis B and C viruses in infants and young children. Semin Pediatr Infect Dis 2005, 16(4):296-305.
• [6]Lewis E, Shinefield HR, Woodruff BA, et al.: Safety of neonatal hepatitis B vaccine administration. Pediatr Infect Dis J 2001, 20:1049-1054.
• [7]Tovo PA, Lazier L, Versace A: Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 2005, 18(3):261-266.
• [8]Van Herck K, Van Damme P: Benefits of early hepatitis B immunization programs for newborns and infants. Pediatr Infect Dis J 2008, 27(10):861-869.
• [9]Papaevangelou V, Hadjichristodoulou C, Cassimos DC, Pantelaki K, Tzivaras A, Hatzimichael A, Theodoridou M: Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination. Infection 2008, 36(2):135-139.
• [10]Case report: encephalomyelitis caused by hepatitis B vaccination. 2007. Available at: http://www.vaclib.org/basic/Case_Report.doc webcite. Accessed: April 29
• [11]Topuridze M, ButsaShvili M, Kamkamidze G, et al.: Hepatitis B vaccine coverage among health care workers: barriers to coverage. Infect Control Hosp Epidemiology 2010, 31(2):158-164.
• [12]Balinska MA: Hepatitis B vaccination and French Society ten years after the suspension of the vaccination campaign: how should we raise infant immunization coverage rates? Review. J Clin Virol 2009, 46(3):202-205. Review
• [13]Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK: Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006, 118(5):e1287-e1292.
• [14]Alavian SM, Mansouri S, Abouzari M, Assari S, Bonab MS, Miri SM: Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil company hospital, Tehran, Iran (1989–2005). Eur J Gastroenterol Hepatol 2008, 20(2):131-134.
• [15]Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, et al.: Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med 1982, 307:1481-1486.
• [16]Mac Mahon BJ, Helminiak C, Wainwright RB, Bulkow L, Wainwright K: Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992, 92:254-256.
• [17]Zanetti AR: Update on hepatitis B vaccination in Italy 10 years after its implementation. Vaccine 2001, 19:2380-2383.
• [18]Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis RF: Hepatitis B infection among health workers in Uganda: evidence of the need for health worker protection. Vaccine 2006, 24(47–48):6930-6937.
• [19]Suckling RM, Taegtmeyer M, Nguku PM, Al-Abri SS, Kibaru J, Chakaya JM, Tukei PM, Gilks CF: Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. J Hosp Infect 2006, 64(3):271-277.
• [20]Talaat M, Kandeel A, El-Shoubary W, Bodenschatz C, Khairy I, Oun S, Mahoney FJ: Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control 2003, 31(8):469-474.
• [21]Simard EP, Miller JT, George PA, Wasley A, Alter MJ, Bell BP, Finelli L: Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002–2003. Infect Control Hosp Epidemiol 2007, 28(7):783-790.
• [22]Batista SMF, Andreas MSA, Borges AMT, Lindenberg ASC, Silva AL, Fernandes TD, Pereira EF, Basmage EAM, Cardoso DDP: Seropositivity for hepatitis B virus, vaccination coverage, and vaccine response in dentists from Campo Grande, Mato Grosso do Sul, Brazil. Mem Inst Oswaldo Cruz 2006, 101(3):263-267.
• [23]Dannetun E, Tegnell A, Torner A, Giesecke J: Coverage of hepatitis B vaccination in Swedish healthcare workers. J Hosp Infect 2006, 63(2):201-204.
• [24]Vranckx R, Jacque P, De Schrijver A, Moens G: Hepatitis B vaccination coverage in Belgian health care workers. Infection 2004, 32(5):278-281.
• [25]Chen W, Gluud C: Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev 2005, 19(4):CD000100.
• [26]Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, Trivello R: Long term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine 2004, 22(5–6):607-610.
• [27]Kuruuzum Z, Yapar N, Avkan-Oguz V, Aslan H, Ozbek OA, Cakir N, Yuce A: Risk of infection in health care workers following occupational exposure to a noninfectious or unknown source. Am J Infect Control 2008, 36(10):e27-e31.
• [28]Tu HA, Woerdenbag HJ, Kane S, Riewpaiboon A, van Hulst M, Postma M: Economic evaluations of hepatitis B vaccination for developing countries. Expert Rev Vaccines 2009, 8(7):907-920.
• [29]National Center Of Disease Control And Public Health (Ncdc), Bulletin. http://www.ncdc.ge/GEO/Publications/Bulletin/ webcite bulletin_2005/Bul_1.pdf